Brief: NLS Pharmaceutics Says On May 16 Co Entered Into Additional Bridge Loan Addendums To Bridge Loan Agreement Dated Nov 15, 2023
22/05/2024 14:19
May 22 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS - ON MAY 16, ENTERED INTO ADDITIONAL
BRIDGE
LOAN ADDENDUMS TO BRIDGE LOAN AGREEMENT DATED NOV 15, 2023
* NLS PHARMACEUTICS AG - ADDITIONAL BRIDGE LOAN ADDENDUMS
PROVIDING FOR EXTENSION OF MATURITY DATE UNDER EACH OF LOAN
AGREEMENTS TO JUNE 30, 2025
Source text for Eikon: ID:n0001213900-24-045730
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing